Researchers are discovering that Vitamin D may be the most important nutrient ever discovered for supporting immune health.*
Regulating the expression of more than 900 genes in your body, vitamin D3 influences just about every function, including healthy cell development and growth, strong bones, cardiovascular health, brain health and cognition.* However, supplementing with just vitamin D isn’t enough.
When you take vitamin D, it is vitally important to also get enough vitamin K2. Not only do the two vitamins work synergistically, vitamin D needs vitamin K2 to function properly. Taken together, vitamins D3 and K2 support your overall heart health, arteries and veins, bone health, and respiratory and immune systems.*
Vitamins D3 & K2:
Supplies 5,000 IU of Vitamin D3, the optimal level providing an effective daily dose for many individuals.
Provides 180 mcg of vitamin K2 as MenaQ7®, the optimal level of K2 in the only patented, clinically supported form on the market today to promote healthy, flexible arteries and overall heart health, as well as bone health.*
Utilizes vitamin K2 produced from chickpeas, which has been proven to be one of the most bioavailable, stable and beneficial varieties.*
Is soy-free to avoid potential allergen concerns.
Uses only non-bioengineered (non-GMO) ingredients
Comes packed in vegetarian-friendly capsules.
Is free from magnesium stearate, a questionable ingredient added to many supplements to enhance product flow but doesn’t provide any nutritive benefits.
With our Vitamins D3 & K2 formula, you get optimal absorption in an easy-to-take, one-a-day capsule serving, unlike some other formulas with MK-4.
Many people have low levels of vitamin D – don’t be one of them. Help safeguard your health, and order Vitamins D3 & K2 today.
Discover more about Vitamins D3 & K2
Are you deficient in Vitamin D? Find out here.
If you have blood coagulation condition or are taking anticoagulants such as Warfarin (Coumadin®), do not use Vitamins D3 & K2.
We are unable to ship this product to Spain and Canada at this time.